Astorg

🤝 𝗜𝘁’𝘀 𝗮𝗻 𝗔𝘀𝘁𝗼𝗿𝗴 𝗗𝗲𝗮𝗹 - 𝗻𝗼𝘄 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝗱!   Astorg is pleased to announce the completion of its acquisition of the global microbiology business from Thermo Fisher Scientific.   When we announced the transaction early this year, we set out a clear ambition: to create an independent, globally scaled microbiology diagnostics specialist.   𝐓𝐨𝐝𝐚𝐲’𝐬 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐢𝐨𝐧 𝐭𝐮𝐫𝐧𝐬 𝐭𝐡𝐚𝐭 𝐚𝐦𝐛𝐢𝐭𝐢𝐨𝐧 𝐢𝐧𝐭𝐨 𝐚𝐜𝐭𝐢𝐨𝐧. The business now begins its journey as an independent company, serving customers across clinical diagnostics, food safety and pharmaceutical applications. With approximately 2,400 employees across 13 manufacturing and R&D sites and more than 15,000 customers across over 100 countries, the company has an exceptional foundation on which to build its next phase of growth.    We are also delighted to welcome Dirk Bontridder as Chief Executive Officer. Dirk brings more than 25 years of international leadership experience across life sciences, diagnostics and industrial technology and will lead the company through this important next chapter. 💬 𝐃𝐢𝐫𝐤 𝐁𝐨𝐧𝐭𝐫𝐢𝐝𝐝𝐞𝐫, 𝐂𝐡𝐢𝐞𝐟 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐎𝐟𝐟𝐢𝐜𝐞𝐫: “𝑇ℎ𝑖𝑠 𝑖𝑠 𝑎 𝑢𝑛𝑖𝑞𝑢𝑒 𝑗𝑜𝑢𝑟𝑛𝑒𝑦 𝑡𝑜 𝑐𝑟𝑒𝑎𝑡𝑒 𝑎𝑛 𝑖𝑛𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑔𝑙𝑜𝑏𝑎𝑙 𝑚𝑖𝑐𝑟𝑜𝑏𝑖𝑜𝑙𝑜𝑔𝑦 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑡𝑖𝑐𝑠 𝑐𝑜𝑚𝑝𝑎𝑛𝑦 𝑤𝑖𝑡ℎ 𝑎𝑛 𝑒𝑥𝑐𝑒𝑝𝑡𝑖𝑜𝑛𝑎𝑙 𝑝𝑜𝑟𝑡𝑓𝑜𝑙𝑖𝑜, 𝑡𝑎𝑙𝑒𝑛𝑡𝑒𝑑 𝑡𝑒𝑎𝑚𝑠 𝑎𝑛𝑑 𝑎 𝑙𝑜𝑛𝑔-𝑠𝑡𝑎𝑛𝑑𝑖𝑛𝑔 𝑟𝑒𝑝𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑞𝑢𝑎𝑙𝑖𝑡𝑦, 𝑠𝑐𝑖𝑒𝑛𝑡𝑖𝑓𝑖𝑐 𝑒𝑥𝑐𝑒𝑙𝑙𝑒𝑛𝑐𝑒 𝑎𝑛𝑑 𝑐𝑢𝑠𝑡𝑜𝑚𝑒𝑟 𝑠𝑒𝑟𝑣𝑖𝑐𝑒.”   This transaction reflects Astorg’s approach at its best: combining deep sector expertise, creative dealmaking and hands-on partnership to unlock the potential of high-quality businesses in complex situations.   We look forward to working closely with Dirk and colleagues around the world as they build the next chapter of this global microbiology diagnostics specialist.  👉 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: https://lnkd.in/eYTsC7wU   Dirk Bontridder | Judith Charpentier | Olivier Lieven | Paul Arhanchiague| Antoine Thomas | Joyce Zhou | Fayçal Battou #Healthcare #LifeSciences #Diagnostics #Microbiology #CarveOut #Dealmaking #ValueCreation   🔵🟢🟠 #Focus #Partnership #Performance

🤝 𝗜𝘁’𝘀 𝗮𝗻 𝗔𝘀𝘁𝗼𝗿𝗴 𝗗𝗲𝗮𝗹 - 𝗻𝗼𝘄 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝗱!   Astorg is pleased to announce the completion of its acquisition of the global microbiology business from Thermo Fisher Scientific.   When we announced the transaction early this year, we set out a clear ambition: to create an independent, globally scaled microbiology diagnostics specialist.   Today’s completion turns that ambition into action. The business now begins its journey as an independent company, serving customers across clinical diagnostics, food safety and pharmaceutical applications. With approximately 2,400 employees across 13 manufacturing and R&D sites and more than 15,000 customers across over 100 countries, the company has an exceptional foundation on which to build its next phase of growth.    We are also delighted to welcome Dirk Bontridder as Chief Executive Officer. Dirk brings more than 25 years of international leadership experience across life sciences, diagnostics and industrial technology and will lead the company through this important next chapter. 💬 Dirk Bontridder, Chief Executive Officer: “This is a unique journey to create an independent global microbiology diagnostics company with an exceptional portfolio, talented teams and a long-standing reputation for quality, scientific excellence and customer service.”   This transaction reflects Astorg’s approach at its best: combining deep sector expertise, creative dealmaking and hands-on partnership to unlock the potential of high-quality businesses in complex situations.   We look forward to working closely with Dirk and colleagues around the world as they build the next chapter of this global microbiology diagnostics specialist.   👉 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: https://lnkd.in/eYTsC7wU   Dirk Bontridder | Judith Charpentier | Olivier Lieven | Paul Arhanchiague | Antoine Thomas | Joyce Zhou | Fayçal Battou #Healthcare #LifeSciences #Diagnostics #Microbiology #CarveOut #Dealmaking #ValueCreation   🔵🟢🟠 #Focus #Partnership #Performance

📍𝗣𝗮𝗿𝗶𝘀 | 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗔𝘀𝘁𝗼𝗿𝗴 𝘁𝗲𝗮𝗺 𝗮𝘁 𝗜𝗣𝗘𝗠 𝗚𝗹𝗼𝗯𝗮𝗹 𝟮𝟬𝟮𝟲   Our team on site includes Benjamin Cordonnier, Judith Charpentier, Lorenzo Zamboni, Lionel de Posson, Keith Beattie, Alexandre Dussaucy, Corinne Schreiber, Reinard Volschenk, Paul Ansah… and colleagues from across Astorg.   We look forward to being at 𝗜𝗣𝗘𝗠 𝗚𝗹𝗼𝗯𝗮𝗹 𝟮𝟬𝟮𝟲 in Paris and reconnecting with investors, partners, portfolio leaders and private markets peers. Reach out or come by our booth — G102, Level 1, Hall Passy — to discuss the themes shaping private markets today.   🔜 More to come from Paris. #IPEM2026 #PrivateMarkets #MidMarket #ValueCreation #Europe #InvestorRelations #Paris 🔵🟢🟠 #Focus #Partnership #Performance

📰 𝗜𝗻 𝘁𝗵𝗲 𝗺𝗲𝗱𝗶𝗮 In a new interview with PE Hub, Judith Charpentier, Astorg’s Co-Managing Partner and Co-Head of the Flagship Fund, discusses how deep sector expertise, creative dealmaking and dedicated value creation capabilities can help build stronger, strategically valuable market leaders. In complex markets, specialization can be a powerful source of opportunity and resilience. 💬 𝐉𝐮𝐝𝐢𝐭𝐡 𝐂𝐡𝐚𝐫𝐩𝐞𝐧𝐭𝐢𝐞𝐫: “𝑊𝑒 𝑓𝑜𝑐𝑢𝑠 𝑜𝑛 𝑐𝑜𝑚𝑝𝑙𝑒𝑥 𝑠𝑖𝑡𝑢𝑎𝑡𝑖𝑜𝑛𝑠 𝑖𝑛 𝑟𝑒𝑠𝑖𝑙𝑖𝑒𝑛𝑡 𝑐𝑎𝑡𝑒𝑔𝑜𝑟𝑖𝑒𝑠. 𝐼𝑛 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑤𝑒 𝑡𝑎𝑟𝑔𝑒𝑡 𝑚𝑒𝑑𝑡𝑒𝑐ℎ 𝑎𝑛𝑑 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑡𝑖𝑐𝑠 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠 𝑤𝑖𝑡ℎ 𝑔𝑟𝑜𝑤𝑡ℎ 𝑝𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝑎𝑛𝑑 𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠, 𝑤ℎ𝑒𝑟𝑒 𝑤𝑒 𝑐𝑎𝑛 𝑐𝑟𝑒𝑎𝑡𝑒 𝑣𝑎𝑙𝑢𝑒 𝑡ℎ𝑟𝑜𝑢𝑔ℎ 𝑐𝑜𝑚𝑝𝑙𝑒𝑥 𝑡𝑟𝑎𝑛𝑠𝑎𝑐𝑡𝑖𝑜𝑛 𝑠𝑡𝑟𝑢𝑐𝑡𝑢𝑟𝑒𝑠 𝑠𝑢𝑐ℎ 𝑎𝑠 𝑐𝑎𝑟𝑣𝑒-𝑜𝑢𝑡𝑠 𝑜𝑟 𝑃2𝑃𝑠, 𝑎𝑛𝑑 𝑏𝑢𝑖𝑙𝑑 𝑚𝑎𝑟𝑘𝑒𝑡 𝑙𝑒𝑎𝑑𝑒𝑟𝑠 𝑤𝑖𝑡ℎ 𝑠𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝑣𝑎𝑙𝑢𝑒.” Judith also shares her perspective on: • Opportunities created by public-market dislocation and corporate portfolio repositioning • Astorg’s approach to complex transactions, including carve-outs and public-to-private investments • The importance of preserving strategic optionality across different exit routes • The value of critical products, global markets and resilient B2B customer bases • The growing role of AI as an enabler of operational performance and value creation across the portfolio 👉 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 with Craig McGlashan on PE Hub: Astorg’s Judith Charpentier: Astorg’s Judith Charpentier: Mid-market focus will maximize exit choices | PE Hub The interview highlights Astorg’s investment approach in Healthcare, including the recently signed acquisition of Thermo Fisher Scientific’s microbiology business and the creation of Nexpring Health through the combination of a public-to-private transaction and two simultaneous carve-outs. It also explores how Astorg is expanding its AI capabilities across the portfolio. By the end of the year, eight members of its Portfolio Performance Team are expected to be dedicated to supporting AI-driven value creation initiatives. As a private equity multi-specialist, Astorg combines deep sector expertise 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬. We partner with ambitious entrepreneurs and management teams in resilient, specialized B2B sectors to help them 𝐠𝐫𝐨𝐰 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐚𝐧𝐝 𝐬𝐜𝐚𝐥𝐞 𝐟𝐚𝐬𝐭𝐞𝐫.  #PEHubEurope #PrivateEquity #MidMarket #ValueCreation #Healthcare #ArtificialIntelligence #Specialization #Leadership 🔵🟢🟠 #Focus #Partnership #Performance

📣 𝗔𝘀𝘁𝗼𝗿𝗴 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗡𝗲𝘄𝘀 We look forward to partner with Todd Morris and the Corsearch team as they embark on this next phase of growth and continue advancing the protection of brand value and Intellectual Property in the AI era. 🤝Since investing in Corsearch in 2021, Astorg has worked closely with the company’s Board and management team, drawing on our deep expertise in Technology and Intellectual Property. Astorg is supporting Corsearch’s value-creation journey through: ✅continued investment in its AI-native platform ✅customer-centric operating model ✅commercial excellence ✅and selective M&A Congratulations to Todd and the Corsearch team. 👉 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗿𝗲𝘀𝘀 𝗿𝗲𝗹𝗲𝗮𝘀𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/eCJH6uZr Corsearch is a global leader in IP Trademark Intelligence and brand protection, combining advanced AI, proprietary data and deep human expertise to help more than 5,000 organizations establish, manage and protect the value of their brands and IP. #PrivateEquity #PortfolioCompany #Leadership #BrandProtection #ArtificialIntelligence #Technology #ValueCreation #focus #Performance #Partnership

📈 𝗩𝗮𝗹𝘂𝗲 𝗰𝗿𝗲𝗮𝘁𝗶𝗼𝗻 𝗶𝘀𝗻'𝘁 𝗮 𝗽𝗿𝗲-𝗲𝘅𝗶𝘁 𝗽𝗵𝗮𝘀𝗲. 𝗜𝘁'𝘀 𝘁𝗵𝗲 𝘄𝗵𝗼𝗹𝗲 𝗵𝗼𝗹𝗱 𝗽𝗲𝗿𝗶𝗼𝗱. A month on from SuperReturn International, one idea continues to stand out: strong value creation is built through continuous improvement, not short-term optimization. Joining industry leaders on SuperReturn's panel, Keith Beattie shared Astorg's perspective on why exit readiness is not a final-stage exercise, but rather the result of well curated and well executed value creation across the lifecycle. 🎙️Keith Beattie, Head of Operations: “As our recent exit of Clario for nearly $9bn demonstrates, the strongest exits are the result of ongoing, repeatable value creation. It is rarely, or ever, created during the exit readiness process itself. Our focus should be on the years spent strengthening the fundamentals of the business, improving its strategic positioning and building an asset that buyers genuinely want to own.” At Astorg, we view exit readiness as the natural culmination of a disciplined value creation journey. By embedding portfolio performance throughout the ownership period – from pre-deal, to strategic repositioning and commercial excellence to operational improvement, digital transformation and talent augmentation – we help our portfolio companies build the capabilities that drive sustainable growth and create stronger outcomes over the long term. 🙏 Thank you to SuperReturn and Boris Hentze, Michael Trihy, CFA, CAIA, Rebecca Gibson, @David Lyon, Larry Aschebrook for driving such an insightful discussion. #ValueCreation #ExitReadiness #OperatingPartners #PrivateMarkets #OperationalExcellence #Focus #Performance #Partnership

🏆 𝗣𝗥𝗜 𝗔𝘄𝗮𝗿𝗱𝘀 𝟮𝟬𝟮𝟲 | 𝗔𝘀𝘁𝗼𝗿𝗴 𝗦𝗵𝗼𝗿𝘁𝗹𝗶𝘀𝘁𝗲𝗱 𝗳𝗼𝗿 𝗖𝗹𝗶𝗺𝗮𝘁𝗲 𝗔𝗰𝘁𝗶𝗼𝗻 We are pleased to share that Astorg has been shortlisted in the category 𝗥𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗔𝗰𝘁𝗶𝗼𝗻: 𝗖𝗹𝗶𝗺𝗮𝘁𝗲 - at the Principles for Responsible Investment Awards 2026. At Astorg, we believe sustainable business performance and long-term value creation go hand in hand. Climate is embedded into our investment approach from day one, with a focus on measurable action and outcomes. With validated science-based targets now in place across 88% of our portfolio by invested capital, we remain focused on continuing to translate ambition into tangible progress across our portfolio. Thank you to Principles for Responsible Investment for including Astorg in this year’s shortlist, and congratulations to all shortlisted organisations. 👉 Read more on the PRI website: https://lnkd.in/ecQAWeBS #PRIAwards #ResponsibleInvestment #ClimateAction #Sustainability #ValueCreation #Impact #Focus #Performance #Partnership

🎾 𝗔𝘀𝘁𝗼𝗿𝗴 𝗣𝗮𝗱𝗲𝗹 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 | 𝟮𝟬𝟮𝟲 𝗘𝗱𝗶𝘁𝗶𝗼𝗻 For the fourth consecutive year, our Frankfurt team brought together colleagues, partners and friends of the firm for the Astorg Padel Challenge. Beyond the competition, it was a great opportunity to spend time together, connect informally and enjoy a moment of fun with people across our ecosystem. Despite the summer heat, the energy on court was high - followed by a BBQ and an evening of conversations and connection. A big thank you to everyone who joined and helped make this year’s edition a success. We look forward to next one in 2027! Florian Luther | Kevin Bernges | Adrian Loeffler | Moritz Kaufhold | Joris Plöns | Jana Schulze #AstorgTeam #LifeAtAstorg #BuildingConnections #AstorgCommunity

🔬 𝗔𝘀𝘁𝗼𝗿𝗴 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟲 | 𝗣𝗮𝗿𝗶𝘀 We recently hosted the second edition of our Healthcare Summit in Paris, bringing together portfolio company CEOs, board members, LPs and senior advisors to exchange perspectives on the themes shaping the sector – from healthcare market dynamics and long-term value creation to China’s emergence as a global innovation hub and AI’s growing impact across healthcare. The objective was clear: to create a focused forum where sector expertise, operational experience and partnership come together to reflect, debate and share meaningful insights. Discussions highlighted the increasing role of China in healthcare innovation and the growing importance of AI across the healthcare value chain, from research and development to diagnostics, operations and patient care. This is how we build conviction: by going deep in the subsectors we know, connecting perspectives across our ecosystem, and partnering with management teams to support the development of international B2B healthcare leaders. Healthcare is Astorg’s largest sector, with approximately €8 billion invested to date, including co-investments, across Pharmaceutical Services and Technology, MedTech and MedTech services, Life Science Tools and Diagnostics. 🤝 Thank you to all our speakers, panelists and participants for making this second edition such a valuable moment for the Astorg Healthcare community. ▶️ 𝗔 𝘀𝗵𝗼𝗿𝘁 𝗹𝗼𝗼𝗸 𝗯𝗮𝗰𝗸 𝗮𝘁 𝘁𝗵𝗲 𝗲𝘃𝗲𝗻𝘁 𝗯𝗲𝗹𝗼𝘄. #HealthcareInvesting #Specialization #ValueCreation #Innovation #Focus #Performance #Partnership

📣 Astorg Portfolio Company News   Astorg is pleased to share that its portfolio company, IPCOM, will acquire a majority stake in Le Froid Pecomark, a leading French distributor of refrigeration, heat pump and ventilation equipment.   The transaction marks another significant milestone in IPCOM’s growth journey, strengthening its HVAC-R platform and further advancing its ambition to become a leading European value-added distributor of energy efficiency solutions.   ➤ Expands IPCOM’s HVAC-R footprint in France through a market leader ➤ Strengthens technical expertise, customer reach and product offering across Europe ➤ Creates additional opportunities to accelerate growth in an attractive, fragmented and synergetic segment    🎯 Since Astorg partnered with IPCOM in 2022, the Group has executed a disciplined buy-and-build strategy with 26 acquisitions, transforming into a fast-growing European platform with more than 100 outlets across 22 countries. HVAC-R is a clear pillar of the M&A strategy with already further acquisitions in sights this year after Triteh and LFP, consolidating leadership positions in other European geographies and bringing HVAC-R at 25% of Group sales by year end.   This latest transaction is another strong example of Astorg’s approach to value creation: partnering with ambitious management teams, backing megatrends with convictions, supporting disciplined M&A execution, and helping build market-leading platforms in resilient, structurally growing markets.   Together, IPCOM and Le Froid Pecomark are well positioned to accelerate growth, deepen customer relationships and further consolidate a highly fragmented European HVAC-R market.   Benjamin Cordonnier, Adrien Celdran, Victor Donsimoni, Remco Boerefijn, Francesco Zito, Kristof Vermeulen   #PortfolioCompany #ValueCreation #BuyandBuild #HVACR #EnergyEfficiency #Distribution #BusinessServices #MergersandAcquisitions #Focus #Partnership #Performance